BBK Worldwide^® Blog

Earlier this week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to discuss the RSG^® Arrive travel program and its recent milestone of 20,000 completed trips.

In this in-depth interview, Mike discusses what sets this program apart from others as he highlights the concierge specialists who are experienced in understanding all the ramifications of a request, not only as it relates to arranging a travel itinerary, but also how to ensure the itinerary supports patient health, safety, and compliance. In addition, Mike shares insight into the significance of the milestone for BBK as well as the industry at-large. Click here to read the full article.

Getting Decentralized Right

What Matters to Patients

In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.

If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.

RSG® Arrive Reaches Milestone of 20,000 Completed Trips

Enrollment, Engagement, and Satisfaction Data Confirms That Extending Study Support Beyond the Care Setting Yields Positive Results

Launched in 2012, RSG® Arrive has made clinical trial participation possible for thousands of patients worldwide. Today, the program has reached a major milestone with the completion of 20,000 trips. 

Getting Decentralized Right

What Matters to Patients

We know the industry is ready to embrace decentralized clinical trials. But what about patients? What do they think about decentralized clinical trials? What elements are important to them? And what should sponsors consider when designing such trials?

To dig deep, we spoke one-on-one with Phil Kelly, a bladder cancer patient and advocate. He shares his experience and insight in Part 1 of this two-part series on the patient perspective.

Think You Know Us? Take Another Look!

View our 2021 Lookbook.

We leverage empathy and care as we get to the heart of the patient experience and what it means to be a study participant in today’s rapidly changing world.

One-on-One with BBK Worldwide Director of Tech Experience Dena Raffa 

There's no question that digital technology is changing the way we engage with patients and altering expectations for the patient experience. As part of our Pharma15 Live! series, we sat down with BBK's Director of Tech Experience Dena Raffa to get her perspective on current trends.

Raffa has been instrumental in many of BBK's software solutions and digital technologies, and most recently she has led the development of BBK's new patient engagement portal - a first of its kind for clinical trial participants.

Create a Patient- and Site-Centric Environment for Decentralized Clinical Trials

Hear from the Experts! 

As decentralized clinical trials reshape the clinical research landscape, BBK Worldwide® Chief Innovation Officer Rob Laurens and Lead Concierge Alex Nicholl discuss efforts to help study sponsors embrace these trials with ease and confidence.

Meaningful Engagement at Critical Touchpoints along the Patient Journey

There's no better way to illustrate the importance of meaningful engagement than with the story of one family's journey from clinical trial awareness to participation. The story shows how the right mix of digital and physical touchpoints plays a critical role in creating a positive patient experience. The family's journey begins below.

New eBook Available for Download

As we continue to focus our attention on underserved populations, we've just released a content-rich eBook full of guidance that study sponsors can leverage to create a more diverse and inclusive clinical trial environment. It features a bonus section with excerpts from our recent Q&A with Michele Russell-Einhorn, chief compliance officer and institutional official at Advarra, that provide an IRB's perspective on improving diversity and inclusion in clinical trials.

Earlier this week, BBK Principal Rob Laurens went one-on-one with Outsourcing-Pharma discussing the launch of BBK's Engagement Solution Center for decentralized and post-marketing clinical trials, which features concierge service delivery and a robust patient experience portal to ease the clinical trial journey.

In this in-depth interview, Rob addresses the importance and advantages of centralizing design, management, operations, and communications of patient support services. In addition, he provides insight into some of the conversations that led to the creation of the center. Click here to read the full article.